Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Angel

Showing results (31-40 of 213) with videos related to

Pageof 22
Sort By:
AIDS Research and Human Retroviruses|July 12, 2011
In vitro HIV Type 1 infection indirectly alters CD127 expression on CD8(+) T cellsAgatha Vranjkovic, Angela M Crawley, Jonathan B Angel
AIDS (London, England)|December 7, 2006
Mitigation of antiretroviral-induced hyperlipidemia by hepatitis C virus co-infectionCurtis L Cooper, Edward Mills, Jonathan B Angel
Journal of Immunology (Baltimore, Md. : 1950)|March 23, 2010
Soluble IL-7R alpha (sCD127) inhibits IL-7 activity and is increased in HIV infectionAngela M Crawley, Sylvie Faucher, Jonathan B Angel
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 24, 1998
Development of cervical fat pads following therapy with human immunodeficiency virus type 1 protease inhibitorsV R Roth, S Kravcik, J B Angel
Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal Officiel De L'Association Pour La Microbiologie Medicale Et L'Infectiologie Canada|July 11, 2025
Pritelivir for the Treatment of Nucleoside Analogue-Resistant Orolabial Herpes Simplex Virus 2 in a Person Living with HIVAndrew Purssell, Kennedy Leung, Pierre Giguère, et al.
The Canadian Journal of Infectious Diseases = Journal Canadien Des Maladies Infectieuses|December 27, 2007
Characteristics of hepatitis C virus infection in HIV-infected peopleC L Cooper, A D Badley, J B Angel
Immunology|August 3, 2010
Interleukin-7 enhances memory CD8(+) T-cell recall responses in health but its activity is impaired in human immunodeficiency virus infectionAlison M O'Connor, Angela M Crawley, Jonathan B Angel
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 10, 2002
Hepatotoxicity associated with antiretroviral therapy containing dual versus single protease inhibitors in individuals coinfected with hepatitis C virus and human immunodeficiency virusCurtis L Cooper, M A Parbhakar, Jonathan B Angel
Clinical and Experimental Immunology|July 24, 2004
Disruption of MAP kinase activation and nuclear factor binding to the IL-12 p40 promoter in HIV-infected myeloid cellsK A Chambers, R J Parks, J B Angel
Cellular Immunology|August 31, 2002
Active cellular infection of myeloid cells is required for HIV-1-mediated suppression of interleukin-12 p40 expressionKelley A Chambers, Karl G Parato, Jonathan B Angel
Pageof 22

Showing results (31-40 of 213) with videos related to

Sort By:
Pageof 22
AIDS Research and Human Retroviruses|July 12, 2011
In vitro HIV Type 1 infection indirectly alters CD127 expression on CD8(+) T cellsAgatha Vranjkovic, Angela M Crawley, Jonathan B Angel
AIDS (London, England)|December 7, 2006
Mitigation of antiretroviral-induced hyperlipidemia by hepatitis C virus co-infectionCurtis L Cooper, Edward Mills, Jonathan B Angel
Journal of Immunology (Baltimore, Md. : 1950)|March 23, 2010
Soluble IL-7R alpha (sCD127) inhibits IL-7 activity and is increased in HIV infectionAngela M Crawley, Sylvie Faucher, Jonathan B Angel
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 24, 1998
Development of cervical fat pads following therapy with human immunodeficiency virus type 1 protease inhibitorsV R Roth, S Kravcik, J B Angel
Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal Officiel De L'Association Pour La Microbiologie Medicale Et L'Infectiologie Canada|July 11, 2025
Pritelivir for the Treatment of Nucleoside Analogue-Resistant Orolabial Herpes Simplex Virus 2 in a Person Living with HIVAndrew Purssell, Kennedy Leung, Pierre Giguère, et al.
The Canadian Journal of Infectious Diseases = Journal Canadien Des Maladies Infectieuses|December 27, 2007
Characteristics of hepatitis C virus infection in HIV-infected peopleC L Cooper, A D Badley, J B Angel
Immunology|August 3, 2010
Interleukin-7 enhances memory CD8(+) T-cell recall responses in health but its activity is impaired in human immunodeficiency virus infectionAlison M O'Connor, Angela M Crawley, Jonathan B Angel
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 10, 2002
Hepatotoxicity associated with antiretroviral therapy containing dual versus single protease inhibitors in individuals coinfected with hepatitis C virus and human immunodeficiency virusCurtis L Cooper, M A Parbhakar, Jonathan B Angel
Clinical and Experimental Immunology|July 24, 2004
Disruption of MAP kinase activation and nuclear factor binding to the IL-12 p40 promoter in HIV-infected myeloid cellsK A Chambers, R J Parks, J B Angel
Cellular Immunology|August 31, 2002
Active cellular infection of myeloid cells is required for HIV-1-mediated suppression of interleukin-12 p40 expressionKelley A Chambers, Karl G Parato, Jonathan B Angel
Pageof 22